Founded Date: 2020-01-01
Last Funding Type: Series A
Headquarters: New York, New York, United States
Investors Number: 8.0
Employee Number: 1-10
Industry: Early Drug Development
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-07-28
Funding Status: Early Stage Venture
Total Funding: 32000000.0